Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Clinical trial NCT00665093 · COMPLETED

Trial details

NCT number: NCT00665093
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2007-05-01
Primary completion: 2008-01-01
Enrollment: 1569

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.